Targeting hepatic macrophages to treat liver diseases.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Hepatology

• Publication date

  2017-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jhep.2017.02.026PMID 28267621
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis.

  2019cited by this paper
• Patients with the worst outcomes after paracetamol (acetaminophen)‐induced liver failure have an early monocytopenia

  2017cited by this paper
• Liver — guardian, modifier and target of sepsis

  2017cited by this paper
• Tissue‐resident macrophages — how to humanize our knowledge

  2017cited by this paper
• Macrophage Polarization.

  2017cited by this paper
• Targeting distinct myeloid cell populations in vivo using polymers, liposomes and microbubbles.

  2017cited by this paper
• Autophagy in chronic liver diseases: the two faces of Janus.

  2017cited by this paper
• Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome.

  2016cited by this paper
• Liver Monocytes and Kupffer Cells Remain Transcriptionally Distinct during Chronic Viral Infection

  2016cited by this paper
• Activation and increase of radio-sensitive CD11b+ recruited Kupffer cells/macrophages in diet-induced steatohepatitis in FGF5 deficient mice

  2016cited by this paper
• Kupffer Cells Undergo Fundamental Changes during the Development of Experimental NASH and Are Critical in Initiating Liver Damage and Inflammation

  2016cited by this paper
• Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis

  2016cited by this paper
• Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis

  2016cited by this paper
• Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression.

  2016cited by this paper
• Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies

  2016cited by this paper
• Combination of Mass Cytometry and Imaging Analysis Reveals Origin, Location, and Functional Repopulation of Liver Myeloid Cells in Mice.

  2016cited by this paper
• Immunology in the liver — from homeostasis to disease

  2016cited by this paper
• Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.

  2016cited by this paper
• Histidine‐rich glycoprotein promotes macrophage activation and inflammation in chronic liver disease

  2016cited by this paper
• CRIg Functions as a Macrophage Pattern Recognition Receptor to Directly Bind and Capture Blood-Borne Gram-Positive Bacteria.

  2016cited by this paper
• CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy.

  2016cited by this paper
• Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission.

  2016cited by this paper
• Transcriptional Control of Dendritic Cell Development.

  2016cited by this paper
• On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver

  2016cited by this paper
• Cenicriviroc placebo for the treatment of non-alcoholic steatohepatitis with liver fibrosis: Results from the Year 1 primary analysis of the Phase 2b CENTAUR study

  2016cited by this paper
• Specification of tissue-resident macrophages during organogenesis

  2016cited by this paper
• Liver Fibrosis: From Pathogenesis to Novel Therapies

  2016cited by this paper
• Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells

  2016cited by this paper
• Bone marrow-derived and resident liver macrophages display unique transcriptomic signatures but similar biological functions

  2016cited by this paper
• Chemokine (C‐C motif) receptor 2–positive monocytes aggravate the early phase of acetaminophen‐induced acute liver injury

  2016cited by this paper
• A Reservoir of Mature Cavity Macrophages that Can Rapidly Invade Visceral Organs to Affect Tissue Repair.

  2016cited by this paper
• CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: Limiting steatohepatitis by maintaining intestinal homeostasis

  2015cited by this paper
• Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH).

  2015cited by this paper
• Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis.

  2015cited by this paper
• Macrophages and Alcohol-Related Liver Inflammation.

  2015cited by this paper
• Alcoholic hepatitis: The pivotal role of Kupffer cells.

  2015cited by this paper
• C-Myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages.

  2015cited by this paper
• Phenotypic and functional characterization of macrophages with therapeutic potential generated from human cirrhotic monocytes in a cohort study

  2015cited by this paper
• The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis.

  2015cited by this paper
• CSF1 Restores Innate Immunity After Liver Injury in Mice and Serum Levels Indicate Outcomes of Patients With Acute Liver Failure

  2015cited by this paper
• Liver inflammation abrogates immunological tolerance induced by Kupffer cells

  2015cited by this paper
• Macrophages: development and tissue specialization.

  2015cited by this paper
• Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma

  2015cited by this paper
• Macrophages and Alcohol-Related Liver Inflammation

  2015cited by this paper
• Kupffer cells interact with hepatitis B surface antigen in vivo and in vitro, leading to proinflammatory cytokine production and natural killer cell function.

  2015cited by this paper
• Inflammatory Monocytes Recruited to the Liver within 24 Hours after Virus-Induced Inflammation Resemble Kupffer Cells but Are Functionally Distinct

  2015cited by this paper
• Kupffer Cells Support Hepatitis B Virus–Mediated CD8+ T Cell Exhaustion via Hepatitis B Core Antigen–TLR2 Interactions in Mice

  2015cited by this paper
• Inflammasome activation and function in liver disease

  2015cited by this paper
• Arginase 2 deficiency results in spontaneous steatohepatitis: a novel link between innate immune activation and hepatic de novo lipogenesis.

  2015cited by this paper
• A dynamic spectrum of monocytes arising from the in situ reprogramming of CCR2+ monocytes at a site of sterile injury

  2015cited by this paper
• Cell therapy for liver disease: From liver transplantation to cell factory.

  2015cited by this paper
• Fluorescent cell-traceable dexamethasone-loaded liposomes for the treatment of inflammatory liver diseases.

  2015cited by this paper
• Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma.

  2015cited by this paper
• Macrophage autophagy protects against liver fibrosis in mice

  2015cited by this paper
• Myeloid cells in hepatocellular carcinoma

  2015cited by this paper
• NKp46+ natural killer cells attenuate metabolism‐induced hepatic fibrosis by regulating macrophage activation in mice

  2015cited by this paper
• Macrophages, immunity, and metabolic disease.

  2014cited by this paper
• Kupffer cell‐derived IL‐10 plays a key role in maintaining humoral immune tolerance in hepatitis B virus‐persistent mice

  2014cited by this paper
• CD141⁺ myeloid dendritic cells are enriched in healthy human liver.

  2014cited by this paper
• Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells.

  2014cited by this paper
• Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors

  2014cited by this paper
• Macrophage activation and polarization: nomenclature and experimental guidelines.

  2014cited by this paper
• Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation

  2014cited by this paper
• Secretory leukocyte protease inhibitor: A pivotal mediator of anti‐inflammatory responses in acetaminophen‐induced acute liver failure

  2014cited by this paper
• Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment.

  2014cited by this paper
• Roles for chemokines in liver disease.

  2014cited by this paper
• Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013.

  2014cited by this paper
• The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease

  2014cited by this paper
• Shaping macrophages function and innate immunity by bile acids: mechanisms and implication in cholestatic liver diseases.

  2014cited by this paper
• Infiltrating Monocyte-Derived Macrophages and Resident Kupffer Cells Display Different Ontogeny and Functions in Acute Liver Injury

  2014cited by this paper
• M2 Kupffer cells promote M1 Kupffer cell apoptosis: A protective mechanism against alcoholic and nonalcoholic fatty liver disease

  2014cited by this paper
• Macrophage heterogeneity in liver injury and fibrosis.

  2014cited by this paper
• Inhibition of Toll-like receptor 4 suppresses liver injury induced by biliary obstruction and subsequent intraportal lipopolysaccharide injection.

  2014cited by this paper
• CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis

  2014cited by this paper
• The role of Kupffer cells in hepatitis B and hepatitis C virus infections.

  2014cited by this paper
• Immune mechanisms in acetaminophen-induced acute liver failure.

  2014cited by this paper
• Therapeutic targeting of liver inflammation and fibrosis by nanomedicine.

  2014cited by this paper
• Pharmacological inhibition of the chemokine C‐C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly‐6C+ macrophage infiltration in mice

  2014cited by this paper
• Chronic alcohol ingestion modulates hepatic macrophage populations and functions in mice

  2014cited by this paper
• Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics

  2013cited by this paper
• Experimental liver fibrosis research: update on animal models, legal issues and translational aspects

  2013cited by this paper
• Contrasting responses of Kupffer cells and inflammatory mononuclear phagocytes to biliary obstruction in a mouse model of cholestatic liver injury

  2013cited by this paper
• Chemokine Receptor CXCR6-Dependent Hepatic NK T Cell Accumulation Promotes Inflammation and Liver Fibrosis

  2013cited by this paper
• Acute liver failure.

  2013cited by this paper
• The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice

  2013cited by this paper
• Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice

  2013cited by this paper
• Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors

  2013cited by this paper
• Role of hepatic resident and infiltrating macrophages in liver repair after acute injury.

  2013cited by this paper
• Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling

  2013cited by this paper
• Hepatitis C Virus Induces Interleukin-1β (IL-1β)/IL-18 in Circulatory and Resident Liver Macrophages

  2013cited by this paper
• Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis

  2012cited by this paper
• Source and characterization of hepatic macrophages in acetaminophen‐induced acute liver failure in humans

  2012cited by this paper
• Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C‐C motif chemokine receptor 8 in mice

  2012cited by this paper
• IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice.

  2012cited by this paper
• Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4.

  2012cited by this paper
• Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2.

  2012cited by this paper
• Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer

  2012cited by this paper
• Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease

  2012cited by this paper
• Characterization of Kupffer cells in livers of developing mice

  2011cited by this paper
• Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury

  2011cited by this paper

• The Causal Effects Between Immune Cells and Cirrhosis: A Bidirectional Two‐Sample Mendelian Randomization Study With Meta‐Analysis

  2026cites this paper
• Bovine Milk-Derived Extracellular Vesicles Attenuate Liver Injury by Modulating the Gut-Liver Axis via Faecalibaculum-Mediated SCFA Production.

  2026cites this paper
• Research on tissue-resident macrophages in the field of cancer research: a bibliometric analysis from 2004 to 2025

  2026cites this paper
• The Impact of Hepatitis B Virus on the Tumor Microenvironment of Hepatocellular Carcinoma and Therapeutic Strategies.

  2026cites this paper
• Pleiotropic immunoregulation by bile acids in pathophysiology.

  2026cites this paper
• Glycyrrhetinic acid ameliorates cholestatic liver injury by inhibiting acHMGB1/TLR2-mediated crosstalk between hepatocytes and macrophages.

  2026cites this paper
• The role of gut microbiota in liver metastasis of small cell lung cancer: mechanisms and therapeutic implications.

  2026cites this paper
• TGFBI promotes liver fibrosis through remodeling the profibrotic microenvironment by a positive feedback regulatory loop.

  2026cites this paper
• Hepatocyte–hepatic stellate cell interactions in liver fibrosis: Mechanisms and therapeutic implications

  2026cites this paper
• Strain-Dependent Effects of Dietary Cholic Acid on Liver Fibrogenesis and Gut Microbiota in TSNO and TSOD Mice.

  2026cites this paper
• Kupffer Cell-Derived Interleukin-6 Aggravates Radiation-Induced Liver Disease by Activating Hepatocyte STAT3 to Promote Ccng1 Transcription.

  2026cites this paper
• Genome-wide CRISPR screen identifies ACSL3 as a regulator of lipotoxicity and progression of MASLD

  2026cites this paper
• The macrophage opera: from metabolic prolog to oncogenic crescendo in metabolic dysfunction-associated steatotic liver disease.

  2026cites this paper
• Annexin A1 enhances liver repair after acetaminophen-induced liver injury by regulating neutrophils function.

  2026cites this paper
• Fucoxanthin mitigates lipopolysaccharide-induced acute liver injury by inhibiting hepatocyte apoptosis and pyroptosis

  2026cites this paper
• The Role and Therapeutic Potential of Voltage‐Gated Potassium Channel Kv1.3 in Metabolism‐Related Disorders

  2026cites this paper
• Macrophage-Targeted Fullerene Potentiates Redox Homeostasis Regulation and Reprograms Macrophage Polarization to Ameliorate Hepatic Steatosis.

  2026cites this paper
• GPR132 drives macrophage M1 polarization and aggravates inflammation-associated liver injury.

  2026cites this paper
• The Role of Kupffer Cells and Liver Macrophages in the Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease

  2026cites this paper
• Infrapatellar Fat Pad in Knee Osteoarthritis: A Comprehensive Review of Pathophysiology and Targeted Therapeutic Strategies

  2025cites this paper
• Glycolysis drives STING signaling to promote M1-macrophage polarization and aggravate liver fibrosis

  2025cites this paper
• New perspectives in the treatment of liver cirrhosis: targeting macrophage regulatory mechanisms

  2025cites this paper
• CXCR6 recruits Th2 cells and promotes liver fibrosis in schistosomiasis japonica

  2025cites this paper
• Therapeutic potentials of mesenchymal stem cells and their extracellular vesicles on liver diseases by modulating mitochondrial function of macrophages.

  2025cites this paper
• Mechanosensitive calcium ion channels Piezo1: A therapeutic target in liver disease

  2025cites this paper
• Macrophage heterogeneity in liver fibrosis

  2025influential citation
• DLGAP5 Promotes Acute Liver Injury via Hepatocyte Pyroptosis-Driven Macrophage Metabolic Reprogramming and M1 Polarization

  2025cites this paper
• Astragaloside IV reduces hepatitis B surface antigen level via monocyte/macrophages in chronic HBV infection mice.

  2025cites this paper
• Bisdemethoxycurcumin suppresses liver fibrosis-associated hepatocellular carcinoma via inhibiting CXCL12-induced macrophage polarization.

  2025cites this paper
• Neonatal Liver-Derived Extracellular Vesicle: Unlocking Mitochondrial Repair and Regenerative Mechanisms in Alcoholic Liver Disease.

  2025cites this paper
• MBD2 deficiency attenuates CCl4-induced hepatic fibrosis by inhibiting M2 macrophage polarization.

  2025cites this paper
• Delivery strategies based on surface-modified nanocarriers conjugated with biomolecular ligands targeting liver receptors.

  2025cites this paper
• Gut-derived indole propionic acid alleviates liver fibrosis by targeting profibrogenic macrophages via the gut‒liver axis

  2025cites this paper
• A Dynamic DNA Nano‐Antioxidant Targeting Galectin‐3 Attenuates Liver Fibrosis via Reducing Macrophage Oxidative Stress

  2025cites this paper
• MASLD development: From molecular pathogenesis toward therapeutic strategies

  2025cites this paper
• Myeloid Glutamine Synthetase Protects Against Acute Liver Injury in Mice Independent of Its Enzyme Activity

  2025cites this paper
• Ethosomes in Integrated Alcoholic Beverages: Unveiling Hidden Dangers and Potential Remedies for Alcoholic Liver Disease.

  2025cites this paper
• Knowledge landscape of macrophage research in liver fibrosis: a bibliometric review of the literature from WoSCC

  2025cites this paper
• Biochemical and Molecular Studies on the Role of Celecoxib and Some Related Bipyrazoles in Mitigating Induced Liver Injury in Experimental Animals

  2025cites this paper
• From Childhood Obesity to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Hyperlipidemia Through Oxidative Stress During Childhood

  2025cites this paper
• Astrocyte Elevated Gene-1/Metadherin (AEG-1/MTDH): A Promising Molecular Marker and Therapeutic Target for Hepatocellular Carcinoma

  2025cites this paper
• Immune-endothelial cell crosstalk in hepatic endothelial injury of liver fibrotic mice.

  2025cites this paper
• Comprehensive study of the murine MASH models' applicability by comparing human liver transcriptomes.

  2025cites this paper
• BMDM-derived ORP8 suppresses lipotoxicity and inflammation by relieving endoplasmic reticulum stress in mice with MASH

  2025cites this paper
• Non-parenchymal cells: key targets for modulating chronic liver diseases

  2025cites this paper
• Myeloid MAS-driven macrophage efferocytosis promotes resolution in ischemia-stressed mouse and human livers.

  2025cites this paper
• Linking necroptosis with liver aging and chronic inflammation in hepatic pathology.

  2025cites this paper
• Unveiling the Role of Sdc4+ Monocytes in NASH: A Single-Cell RNA Sequencing Study

  2025cites this paper
• 8-Methoxybicolosin C from Lespedeza bicolor Attenuates Inflammation and Oxidative Stress via Nrf2/HO-1 and NF-κB/MAPK Pathways in Lipopolysaccharide-Induced Mouse Kupffer Cells

  2025cites this paper
• 3D hESC Exosome‐Derived Circular RNA hsa_circ_0076798 Inhibits M1 Macrophage Inflammatory Response and Alleviates Liver Fibrosis by Suppressing TNF/NF‐κB Pathway Through miR‐1184/DICER1 Axis

  2025cites this paper
• Microbiome-derived bile acids as endogenous regenerative mediators in liver repair

  2025cites this paper
• Arctigenin Prevents Metabolic Dysfunction-associated Steatohepatitis by Inhibiting NLRP3/GSDMD-N Axis in Macrophages

  2025cites this paper
• Intracellular IL1α in Peritumoral Monocytes Induces IL8 Production and Inhibits Mitophagy to Promote Stemness and Metastasis of Hepatocellular Carcinoma

  2025cites this paper
• Fucoidan from Fucus vesiculosus alleviates MetALD via promoting HIF-1α ubiquitination to suppress peripheral monocyte infiltration

  2025cites this paper
• Krüppel-like factor 15 ameliorates alcohol-induced liver injury in mice via regulation of the PFKFB3/AKT axis

  2025cites this paper
• Chemotaxis-guided nanoplatform for non-alcoholic steatohepatitis therapy via macrophage reprogramming, hepatoprotection and gut microbiome modulation.

  2025cites this paper
• Bile acid signaling in MASLD: from pathogenesis to therapeutic applications.

  2025cites this paper
• Advances in understanding the mechanism of noncoding RNA (ncRNA)-mediated regulation of macrophage polarization in NAFLD.

  2025cites this paper
• DPP7 promotes fatty acid β-oxidation in tumor-associated macrophages and determines immunosuppressive microenvironment in colorectal cancer

  2025cites this paper
• Interactions between hepatic stellate cells and immune cells: Implications for liver fibrosis.

  2025cites this paper
• AXL activation governs the liver microenvironment to protect ischemia–reperfusion injury by suppressing NLRP3 inflammasome

  2025cites this paper
• BRD2 promotes inflammation and lipid accumulation through the NF-κB pathway in alcoholic liver injury.

  2025cites this paper
• Macrophage PKM2 depletion ameliorates hepatic inflammation and acute liver injury in mice

  2025cites this paper
• Ginsenoside Rh2 Mitigates Endoplasmic Reticulum Stress-Induced Apoptosis and Inflammation and Through Inhibition of Hepatocyte–Macrophage Inflammatory Crosstalk

  2025cites this paper
• The Beneficial Effects of Resveratrol on Hepatocellular Carcinoma and Nonalcoholic Fatty Liver Disease: Modulation of Apoptosis, Autophagy, Inflammation, and Oxidative Stress

  2025cites this paper
• Inflammation in MASLD progression and cancer

  2025cites this paper
• Recompensation in Cirrhosis: Biomarkers and Strategies

  2025cites this paper
• Characterisation of macrophages in healthy and diseased livers in mice: identification of necrotic lesion-associated macrophages

  2025cites this paper
• Gold nanoparticles modulate macrophage polarization to promote skeletal muscle regeneration

  2025cites this paper
• Perisurgical Colony Stimulating Factor 1 (CSF1) treatment ameliorates liver ischaemia/reperfusion injury in rats

  2025cites this paper
• Common immunotoxicity mechanisms of hepatotoxicity induced by raw Polygonum multiflorum and Polygonum multiflorum praeparata: inhibition of M2 macrophage polarization.

  2025cites this paper
• Mechanisms of Targeted Drug Delivery for Liver Cancer: Active, Passive, and Subcellular Strategies

  2025cites this paper
• The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions

  2025cites this paper
• Macrophage-specific PHGDH protects against MAFLD by suppressing TAK1.

  2025cites this paper
• Gut microbiota and HMGB1/NLRP3/GSDMD inflammasome-dependent pyroptosis: mechanisms by physcion ameliorates alcoholic liver fibrosis

  2025cites this paper
• Luteolin modulates liver macrophage subtype polarization and play protective role in sepsis induced acute hepatic injury

  2025cites this paper
• Roles of the gut microbiota in hepatocellular carcinoma: from the gut dysbiosis to the intratumoral microbiota

  2025cites this paper
• Mindin orchestrates the macrophage-mediated resolution of liver fibrosis in mice

  2025cites this paper
• Single-cell profiling reveals monocyte heterogeneity and association with liver fibrosis in patients with chronic HBV

  2025cites this paper
• An inverted U-shaped association between high-sensitivity C-reactive protein and the albumin ratio and hepatic steatosis and liver fibrosis: a population-based study

  2025cites this paper
• IQGAP-1 mediated activation of the kupffer cells contributes to the progression of MASLD.

  2025cites this paper
• Anti‐Tumour Immunity Relies on Targeting Tissue Homeostasis Through Monocyte‐Driven Responses Rather Than Direct Tumour Cytotoxicity

  2025cites this paper
• Nanoparticle-mediated dual targeting of stromal and immune components to overcome fibrotic and immunosuppressive barriers in hepatocellular carcinoma.

  2025cites this paper
• Dehydrotrametenolic acid methyl ester, a triterpenoid of Poria cocos, alleviates non-alcoholic steatohepatitis by suppressing NLRP3 inflammasome activation via targeting Caspase-1 in mice

  2025cites this paper
• High metastatic tumor-derived CXCL16 mediates liver colonization metastasis by inducing Kupffer cell polarization via the PI3K/AKT/FOXO3a pathway

  2025cites this paper
• Navigating the Paradox of IL‐22: Friend or Foe in Hepatic Health?

  2025cites this paper
• Reviewing the function of macrophages in liver disease

  2025cites this paper
• Immunological mechanisms and emerging therapeutic targets in alcohol-associated liver disease

  2025cites this paper
• The Liver in Diabetes and Metabolic Syndrome

  2025cites this paper
• Rhein Alleviates Pancreatitis but Induces Hepatotoxicity via Macrophage Activation.

  2025cites this paper
• Dietary procyanidin B1 attenuates fibrogenesis and inflammation in hepatic fibrosis: research on the possible health benefits of procyanidin B1.

  2025cites this paper
• Critical Role of Cholic Acid in the Development of iHFC Diet-induced MASH in TSNO Mice

  2025cites this paper
• Autoimmunity in MASLD: Focus on autoantibodies, anti‐apolipoprotein A1 IgG and G protein‐coupled receptors

  2025cites this paper
• Perisurgical colony stimulating factor one treatment ameliorates liver ischaemia/reperfusion injury in rats

  2025cites this paper
• Advances in Tumor Microenvironment and Immunotherapeutic Strategies for Hepatocellular Carcinoma

  2025cites this paper
• Advances in the Use of Traditional Chinese Medicine in Hepatic Fibrosis Treatment

  2025cites this paper
• Endothelial Tgfbr2 Deficiency Ameliorate Liver Fibrosis Through Regulating Angiocrine Signalling and Macrophage Accumulation

  2025cites this paper
• A novel extracellular mannan from Bacillus velezensis ameliorates metabolic-associated fatty liver disease by modulating gut microbiota in mice model.

  2025cites this paper
• A novel Kupffer cell-targeting nanoparticle system to Mitigate alcohol-associated liver disease

  2025cites this paper
• Single-cell RNA sequencing advances in revealing the development and progression of MASH: the identifications and interactions of non-parenchymal cells

  2025cites this paper